dihydrochelerythrine and Hepatitis-B

dihydrochelerythrine has been researched along with Hepatitis-B* in 1 studies

Reviews

1 review(s) available for dihydrochelerythrine and Hepatitis-B

ArticleYear
A review of non-nucleoside anti-hepatitis B virus agents.
    European journal of medicinal chemistry, 2014, Mar-21, Volume: 75

    Hepatitis B Virus is the most common cause of chronic liver disease worldwide. Currently approved agents of chronic HBV infection treatment include interferon and nucleoside analogues. However, the side effects of interferon and the viral resistance of nucleoside analogues make the current treatment far from satisfactory. Therefore, new drugs with novel structures and mechanisms are needed. Recently, a number of non-nucleoside HBV inhibitors have been obtained from natural sources or prepared by synthesis/semi-synthesis. Some of them exhibited potent anti-HBV activity with novel mechanisms. These compounds provide useful information for the medicinal chemist to develop novel non-nucleoside compounds as anti-HBV agents.

    Topics: Animals; Antiviral Agents; Biological Products; Hepatitis B; Hepatitis B virus; Humans; Small Molecule Libraries

2014